Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Acta Haematologica|January 13, 2001
Littoral cell angioma associated with portal hypertension and resected colon cancerD P Steensma, W G MoriceHuman Pathology|July 4, 1998
Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistryW G Morice, J A FerreiroLeukemia & Lymphoma|May 30, 2001
Natural killer cells and the syndrome of chronic natural killer cell lymphocytosisW G Morice, P J Leibson, A TefferiThe Journal of Biological Chemistry|October 25, 1993
Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytesW G Morice, G Wiederrecht, G J Brunn, et al.The Journal of Biological Chemistry|February 15, 1993
Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytesW G Morice, G J Brunn, G Wiederrecht, et al.Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.Leukemia|December 19, 2015
CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic valueA Pardanani, K K Reichard, D Zblewski, et al.Leukemia|March 13, 2014
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myelomaW I Gonsalves, S V Rajkumar, V Gupta, et al.Leukemia|April 11, 2008
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomasA L Feldman, D X Sun, M E Law, et al.Leukemia|July 27, 2016
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progressionW I Gonsalves, S V Rajkumar, A Dispenzieri, et al.Pageof 1